Immunovia presents data from discovery study at 2024 PancreasFest medical conference
LUND, Sweden, July 25, 2024 /PRNewswire/ — Immunovia (Nasdaq Stockholm: IMMNOV), the pancreatic cancer diagnostics company, today presented detailed discovery study results for the company’s next-generation early detection test for pancreatic …